Results overview: Found 6 records in 0.01 seconds.
Articles, 5 records found
Research literature, 1 records found
Articles 5 records found  
1.
12 p, 1.7 MB Ligand-dependent Hedgehog pathway activation in Rhabdomyosarcoma : the oncogenic role of the ligands / Almazán-Moga, A (Hospital Universitari Vall d'Hebron) ; Zarzosa, P (Hospital Universitari Vall d'Hebron) ; Molist, C (Hospital Universitari Vall d'Hebron) ; Velasco, Pablo (Universitat Autònoma de Barcelona. Departament de Pediatria, Obstetrícia i Ginecologia i Medicina Preventiva i Salut Pública) ; Pyczek, J (Institute of Human Genetics, University of Goettingen) ; Simon-Keller, K (Institute of Pathology, University Medical Centre Mannheim, University of Heidelberg) ; Giralt, Irina (Hospital Universitari Vall d'Hebron) ; Vidal, I (Hospital Universitari Vall d'Hebron) ; Navarro, N (Hospital Universitari Vall d'Hebron) ; Segura, M F (Hospital Universitari Vall d'Hebron) ; Soriano, A (Hospital Universitari Vall d'Hebron) ; Navarro, S (Universitat de València. Departament de Patologia) ; Tirado, O M (Institut d'Investigació Biomèdica de Bellvitge) ; Ferreres, J C (Hospital Universitari Vall d'Hebron) ; Santamaria, A (Hospital Universitari Vall d'Hebron) ; Rota, R (Ospedale Pediatrico Bambino Gesù, IRCCS) ; Hahn, H (Institute of Human Genetics, University of Goettingen) ; Sánchez de Toledo, J (Hospital Universitari Vall d'Hebron) ; Roma, J (Hospital Universitari Vall d'Hebron) ; Gallego, S (Hospital Universitari Vall d'Hebron)
Rhabdomyosarcoma (RMS) is the most common type of soft tissue sarcoma in children. The Hedgehog (HH) pathway is known to develop an oncogenic role in RMS. However, the molecular mechanism that drives activation of the pathway in RMS is not well understood. [...]
2017 - 10.1038/bjc.2017.305
British Journal of Cancer, Vol. 117 (09 2017) , p. 1314-1325  
2.
14 p, 3.4 MB Hedgehog Pathway Inhibition Hampers Sphere and Holoclone Formation in Rhabdomyosarcoma / Almazán-Moga, A (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Zarzosa, Patricia (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Vidal, Isaac (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Molist, Carla (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Giralt, Irina (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Navarro, Natalia (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Soriano, Aroa (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Segura, Miguel F. (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Alfranca, Arantza (Cellular Biotechnology Unit, Instituto de Salud Carlos III, Madrid) ; Garcia-Castro, Javier (Cellular Biotechnology Unit, Instituto de Salud Carlos III, Madrid) ; Sánchez de Toledo, José (Universitat Autònoma de Barcelona. Departament de Pediatria, Obstetrícia i Ginecologia i Medicina Preventiva i Salut Pública) ; Roma, Josep (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Gallego, Soledad (Universitat Autònoma de Barcelona. Departament de Pediatria, Obstetrícia i Ginecologia i Medicina Preventiva i Salut Pública)
Rhabdomyosarcoma (RMS) is the most common type of soft tissue sarcoma in children and can be divided into two main subtypes: embryonal (eRMS) and alveolar (aRMS). Among the cellular heterogeneity of tumors, the existence of a small fraction of cells called cancer stem cells (CSC), thought to be responsible for the onset and propagation of cancer, has been demonstrated in some neoplasia. [...]
2017 - 10.1155/2017/7507380
Stem Cells International, Vol. 2017 (january 2017)  
3.
17 p, 5.7 MB MicroRNA-497 impairs the growth of chemoresistant neuroblastoma cells by targeting cell cycle, survival and vascular permeability genes / Soriano, Aroa (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; París-Coderch, Laia (Universitat Autònoma de Barcelona. Departament de Bioquímica i de Biologia Molecular) ; Jubierre, Luz (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Martínez, Alba (Tumor Angiogenesis Group, Catalan Institute of Oncology-IDIBELL) ; Zhou, Xiangyu (Universitat Autònoma de Barcelona. Institut de Neurociències) ; Piskareva, Olga (Molecular and Cellular Therapeutics, Royal College of Surgeons in Ireland and National Children's Research Centre Our Lady's Children's Hospital) ; Bray, Isabella (Molecular and Cellular Therapeutics, Royal College of Surgeons in Ireland and National Children's Research Centre Our Lady's Children's Hospital) ; Vidal, Isaac (Universitat Autònoma de Barcelona. Departament de Bioquímica i de Biologia Molecular) ; Almazán-Moga, A (Universitat Autònoma de Barcelona. Departament de Bioquímica i de Biologia Molecular) ; Molist, Carla (Universitat Autònoma de Barcelona. Departament de Bioquímica i de Biologia Molecular) ; Roma, Josep (Universitat Autònoma de Barcelona. Departament de Bioquímica i de Biologia Molecular) ; Bayascas Ramírez, José Ramón. (Universitat Autònoma de Barcelona. Institut de Neurociències) ; Casanovas, Oriol (Tumor Angiogenesis Group, Catalan Institute of Oncology-IDIBELLL'Hospitalet de Llobregat) ; Stallings, Raymond L. (Molecular and Cellular Therapeutics, Royal College of Surgeons in Ireland and National Children's Research Centre Our Lady's Children's Hospital) ; de Toledo, José Sánchez (Universitat Autònoma de Barcelona. Departament de Bioquímica i de Biologia Molecular) ; Gallego, Soledad (Universitat Autònoma de Barcelona. Departament de Bioquímica i de Biologia Molecular) ; Segura, Miguel F. (Universitat Autònoma de Barcelona. Departament de Bioquímica i de Biologia Molecular) ; Universitat Autònoma de Barcelona. Vall d'Hebron Institut de Recerca (VHIR)
Despite multimodal therapies, a high percentage of high-risk neuroblastoma (NB) become refractory to current treatments, most of which interfere with cell cycle and DNA synthesis or function, activating the DNA damage response (DDR). [...]
2016 - 10.18632/oncotarget.7005
Oncotarget, Vol. 7 (january 2016) , p. 9271-9287  
4.
10 p, 2.0 MB Notch-mediated induction of N-cadherin and α 9-integrin confers higher invasive phenotype on rhabdomyosarcoma cells / Masià, A (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Almazán-Moga, A (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Velasco, P (Hospital Universitari Vall d'Hebron) ; Reventós, J (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Torán, N (Hospital Universitari Vall d'Hebron) ; Sánchez de Toledo, J (Hospital Universitari Vall d'Hebron) ; Roma, J (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Gallego, S (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Universitat Autònoma de Barcelona
Rhabdomyosarcoma (RMS) is the commonest type of soft-tissue sarcoma in children. Patients with metastatic RMS continue to have very poor prognosis. Recently, several works have demonstrated a connection between Notch pathway activation and the regulation of cell motility and invasiveness. [...]
2012 - 10.1038/bjc.2012.411
British Journal of Cancer, Vol. 107 (09 2012) , p. 1374-1383  
5.
7 p, 573.6 KB Notch, Wnt, and Hedgehog Pathways in Rhabdomyosarcoma : From Single Pathways to an Integrated Network / Roma, Josep (Hospital Universitari Vall d'Hebron) ; Almazán-Moga, Anna (Hospital Universitari Vall d'Hebron) ; Sánchez de Toledo, Josep (Hospital Universitari Vall d'Hebron) ; Gallego, Soledad (Hospital Universitari Vall d'Hebron) ; Universitat Autònoma de Barcelona
Rhabdomyosarcoma (RMS) is the most common type of soft tissue sarcoma in children. Regarding histopathological criteria, RMS can be divided into 2 main subtypes: embryonal and alveolar. These subtypes differ considerably in their clinical phenotype and molecular features. [...]
2012 - 10.1155/2012/695603
Sarcoma, Vol. 2012 (march 2012)  

Research literature 1 records found  
1.
247 p, 5.3 MB Caracterización del mecanismo de activación de la vía Hedgehog en el rabdomiosarcoma : el papel oncogénico de los ligandos / Almazán-Moga, A ; Gallego Melcón, Soledad, dir. (Universitat Autònoma de Barcelona. Departament de Pediatria, Obstetrícia i Ginecologia i Medicina Preventiva i Salut Pública) ; Roma Castanyer, Josep, dir. ; Bayascas Ramírez, José Ramón, dir. (Universitat Autònoma de Barcelona. Departament de Bioquímica i de Biologia Molecular) ; Universitat Autònoma de Barcelona. Departament de Bioquímica i de Biologia Molecular
El rabdomiosarcoma (RMS) es el sarcoma de partes blandas más común en la infancia y se considera que se origina en células embrionarias destinadas a la formación de músculo esquelético. Histológicamente, el RMS se divide en 2 grupos principales: embrionario (RMSe) y alveolar (RMSa), los cuales difieren tanto en su presentación clínica, respuesta a terapia y pronóstico, siendo el subtipo alveolar el que presenta un pronóstico más desfavorable. [...]
Rhabdomyosarcoma (RMS) is the most common soft tissue sarcoma in children and is thought to derive from embryonic cells committed to developing into skeletal muscle. Histologically, RMS is divided into 2 major subtypes: embryonal (eRMS) and alveolar (aRMS), which differ in their clinical presentation, response to therapy and prognostic, being the alveolar subtype the most aggressive. [...]

[Barcelona] : Universitat Autònoma de Barcelona, 2016  

See also: similar author names
1 Almazán-Moga, Anna
Interested in being notified about new results for this query?
Set up a personal email alert or subscribe to the RSS feed.